The phenomenon previously known as “Paxlovid rebound” is now recognized as “COVID rebound,” where symptoms of COVID-19 reappear after starting antiviral treatment, even without taking antivirals.
“COVID rebound” is not exclusive to COVID-19 itself, but advancements in technology such as rapid antigen tests allow for close monitoring of infection progression, as stated by virologist Dr. Andy Pekosz from the Department of Molecular Microbiology and Immunology.
Ongoing research aims to comprehend COVID rebound, its contagiousness, and the effects of antivirals like Paxlovid. Despite mild rebound symptoms, the benefits of Paxlovid for high-risk individuals should not be underestimated, notes infectious disease expert Dr. Amesh Adalja from Johns Hopkins Center for Health Security.
Understanding COVID Rebound
According to the CDC, COVID rebound refers to the recurrence of symptoms or a positive viral test following recovery from COVID-19. These rebound symptoms are generally mild, with no severe outcomes reported so far, as per a CDC report from December 2023.
Causes of COVID Rebound
Ongoing research is focused on understanding the factors contributing to rebound. Virologists suggest that the complex immune response and fluctuations in virus levels during infection play a role in the rebound phenomenon.
Role of Paxlovid in Rebound
Studies have not established a consistent link between Paxlovid treatment and rebound symptoms. Rebound might occur in some individuals post-treatment due to changes in immune response dynamics.
The potential for rebound should not discourage high-risk individuals from taking Paxlovid, as it significantly reduces the risk of severe disease, according to Dr. Pekosz.
Possibility of COVID Rebound without Paxlovid
Cases of COVID rebound have been documented before Paxlovid was available, indicating that rebound can occur irrespective of treatment. Fluctuations in viral load and infectivity are common during a COVID infection.
Contagiousness During Rebound
The contagiousness during rebound is more closely related to test positivity than symptoms. A positive result on an antigen test may indicate infectivity.
Comparison of Rebound with Other Viruses
Similar rebound phenomena may occur with other viral infections such as flu and RSV. The advanced testing capabilities for COVID surpass those for other viruses, aiding in understanding such variations.
Rebound COVID, also known as COVID relapse, refers to the reappearance of COVID-19 symptoms after a period of recovery. Our team has compiled a comprehensive overview of rebound COVID to address concerns and provide guidance on managing symptoms.
What is rebound COVID?
Rebound COVID occurs when symptoms or positive COVID tests return following initial recovery. It differs from long COVID and does not pose an increased risk of severe outcomes or death.
What causes COVID rebound?
Factors such as weakened immunity, underlying health conditions, and smoking habits increase the risk of rebound COVID. Rebound can occur with or without antiviral treatment like Paxlovid or Molnupiravir.
What are typical COVID rebound symptoms?
Symptoms of rebound COVID are typically milder than initial symptoms and may include fatigue, cough, or fever. It is important to monitor your symptoms closely and seek medical advice if necessary. In some cases, symptoms of rebound COVID may also include loss of taste or smell, body aches, sore throat, or shortness of breath. If you experience any new or worsening symptoms, it is important to contact your healthcare provider for guidance on next steps.
How long does COVID rebound last?
The timeline of rebound COVID varies among individuals, but symptoms usually resurface within a week after initial recovery and resolve in about 6 days.
It is important to note that the duration of COVID rebound can also depend on factors such as the individual’s overall health, age, and any underlying medical conditions. It is always recommended to consult with a healthcare provider for personalized guidance on managing COVID symptoms during the rebound period.
How to treat COVID rebound?
Home remedies such as painkillers, fever reducers, and cough relief measures can effectively manage symptoms of rebound COVID. Most people will find relief as their immune system fights the infection. High-risk individuals should consult their healthcare provider for possible treatment options to prevent severe illness or hospitalization.
- Gradually feeling worse
- Difficulty breathing when standing upright
- Feeling very weak, and basic tasks feel too difficult
- Shaking or shivering
- Feeling unwell after a month
If experiencing a rebound, it’s crucial to know that you are contagious. Maintain a safe distance from others, especially those at high risk of severe illness from the coronavirus.
It is important to rest and stay hydrated when experiencing a rebound of COVID. Getting plenty of rest can help your body fight off the infection more effectively. Make sure to drink lots of fluids to stay hydrated and help alleviate symptoms such as fever and cough.
In addition to home remedies, it may be necessary to seek medical attention if symptoms worsen or if you have underlying health conditions that put you at higher risk. Your healthcare provider can provide guidance on the best course of action and treatment options to manage your symptoms and prevent complications.
Wrapping up
Recurrent symptoms during rebound COVID are generally mild compared to initial COVID-19 symptoms. It is important to continue monitoring your symptoms closely and seek medical assistance if you have underlying conditions that may increase the risk of severe illness from the virus. In addition, staying informed about updates and guidelines from health authorities can help you to protect yourself and others during this challenging time.
COVID-19 rebound symptoms FAQs
Q: Can you feel better then feel sick again with COVID-19?
A: Yes, this is known as rebound COVID or COVID relapse.
Q: Is rebound COVID worse?
A: Rebound COVID symptoms are typically milder than symptoms from the initial infection.
Q: What should you do about rebound COVID?
A: Rest, stay hydrated, seek medical help if at risk of severe illness, and maintain distance from others as you are still contagious.
Q: Are you contagious with rebound COVID?
A: Yes, keep your distance from others.
Q: Can COVID rebound after 2 weeks?
A: Yes, it’s possible to experience rebound COVID after 2 weeks.
CDC (2024). Symptoms of COVID-19. Accessed on March 10, 2025.
County of LA public health (2024). Medicine to treat COVID-19. Accessed on February 18, 2024.
CDC (2024). Types of COVID-19 Treatment. Accessed on March 10, 2025.
NHS (2023). COVID-19 symptoms and what to do. Accessed on March 10, 2025.
Just when you thought you had overcome COVID-19, your symptoms return. This is not long COVID-19 or a reinfection but a case of rebound COVID-19, where symptoms reappear shortly after feeling better.
Here’s what you need to know about rebound COVID-19.
“Experiencing a rebound after recovering from a cold is not uncommon.”
Who gets rebound COVID-19?
Rebound COVID-19 may impact up to 10% of patients and could be more prevalent in those treated with Paxlovid. Continuous symptom monitoring and prompt medical attention if needed are essential.
“It’s crucial to clarify that Paxlovid is not the cause of the rebound,” Dr. Soniya Gandhi emphasizes.
Soniya S. Gandhi, MD, MPH
Soniya S. Gandhi is a board-certified physician with a Master of Public Health degree. She specializes in internal medicine and has a strong background in public health research and advocacy.
Dr. Gandhi is passionate about promoting preventive healthcare and working towards improving healthcare access for underserved communities. She is actively involved in community outreach programs and volunteers her time to provide medical care to those in need.
In addition to her clinical work, Dr. Gandhi is also involved in teaching and mentoring medical students and residents. She is dedicated to educating the next generation of healthcare professionals and instilling in them the importance of compassionate and evidence-based care.
Soniya S. Gandhi, MD, MPH
Soniya S. Gandhi is a medical doctor with a Master’s in Public Health. She specializes in infectious diseases and has conducted research on global health issues. Dr. Gandhi has worked in various healthcare settings, both domestically and internationally, and is dedicated to improving healthcare access and outcomes for underserved populations. She is passionate about community health education and advocacy, and frequently volunteers her time to provide medical care in low-income communities. Dr. Gandhi is a respected member of the medical community and is known for her compassionate and patient-centered approach to healthcare.
Why is rebound COVID more common after treatment?
The rebound is not due to a weak immune response or Paxlovid inefficacy. It could be a temporary virus surge after treatment cessation, leading to symptom recurrence. Longer treatment duration or a second round of Paxlovid might be considered.
How do I know if I am experiencing a rebound?
If you suspect rebound symptoms, self-isolate for five days and wear a mask. Consult your healthcare provider for guidance. Some individuals may test positive without exhibiting symptoms. Rebound may also occur with other respiratory illnesses.
What else should I know?
Do not fear COVID-19 treatment. Paxlovid is effective and not linked to severe illness. Symptoms are typically mild and resolve within days.
Various viruses can lead to persistent symptoms post-infection. Long COVID affects a significant number of individuals, contributing to improved understanding and treatment strategies.
Individuals infected with COVID are more prone to long-lasting symptoms compared to those without infection. Treatment facilities specializing in Long COVID and post-acute infection syndromes are available.
Yale’s Center for Infection & Immunity focuses on enhancing knowledge of infectious diseases, particularly post-acute infection syndromes like Long COVID, post-treatment Lyme disease, and ME/CFS.
Dr. Akiko Iwasaki, an immunobiologist at Yale and director of the Center for Infection & Immunity, aims to prevent or cure post-acute infection syndromes through in-depth studies of the biological mechanisms underlying these conditions.
Below, Dr. Iwasaki discusses the current knowledge and uncertainties surrounding Long COVID and other post-acute infection syndromes.
It is important to continue monitoring for any new symptoms or changes in health after recovering from COVID-19, as post-acute infection syndromes can develop weeks or even months after the initial infection. Seeking medical attention and support from specialized treatment facilities can help in managing and treating these conditions effectively.
Research is ongoing to better understand the long-term effects of COVID-19 and other viral infections, with a focus on developing targeted therapies and interventions to alleviate symptoms and improve quality of life for those affected by post-acute infection syndromes.
Education and awareness about Long COVID and related conditions are crucial in promoting early detection, diagnosis, and treatment, as well as in providing support and resources for individuals experiencing prolonged or persistent symptoms following an infection.
Post-Acute Infection Syndrome
This spectrum encompasses chronic conditions arising after infections caused by viruses, bacteria, or parasites. For instance, it can result in prolonged symptoms following COVID, viral infections, or bacterial Lyme disease.
The prevalence of these syndromes varies depending on the pathogen. Long COVID affects about 10% of individuals with COVID, while seasonal flu likely has a lower rate of post-acute cases.
Conditions like ME/CFS, characterized by severe fatigue and sleep disturbances, may have multiple origins, including viral infections. Over time, Long COVID and other syndromes may progress to ME/CFS.
Explaining Post-Acute Infection Syndrome
Researchers propose four hypotheses to elucidate the triggers for post-acute infection syndromes, including persistent viral infections, autoimmune responses, latent virus reactivation, and chronic inflammation leading to tissue damage.
Research and Treatment
Research is underway to comprehend and manage chronic diseases like long COVID. Studies such as the Paxlovid trial investigate potential treatments and biomarkers for these syndromes.
Understanding disease mechanisms will inform the development of therapies to effectively treat these conditions.
Prevention Strategies
Vaccination plays a vital role in preventing chronic diseases like COVID, pneumonia, flu, RSV, and chickenpox. Standard preventive measures, seasonal vaccines, and maintaining optimal indoor humidity levels can further reduce the risk of infection.
The Influence of Humidity on Airborne Virus Spread and Immune Response
According to Iwasaki’s study, humidity levels play a crucial role in the transmission of airborne viruses and how the body defends itself against pathogens. It is suggested to maintain indoor humidity within the range of 40% to 60% by using a humidifier.